LAMP-1/CD107a Antibody (H4A3) - Azide and BSA Free | Novus Biologicals NBP2-25183 product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

LAMP-1/CD107a Antibody (H4A3) - Azide and BSA Free

catalog :

NBP2-25183

quantity :

0.1 mg

price :

409 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

H4A3

reactivity :

human, mouse

application :

western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section

more info or order :

Novus Biologicals product webpage

citations: 16

Reference
Lin S, Wu C, Tseng T, Jhang Y, Lee S. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation. Biochem Cell Biol. 2019;: pubmed publisher
Twomey J, Zhang B. Circulating Tumor Cells Develop Resistance to TRAIL-Induced Apoptosis Through Autophagic Removal of Death Receptor 5: Evidence from an In Vitro Model. Cancers (Basel). 2019;11: pubmed publisher
Sharpe B, Alghezi D, Cattermole C, Beresford M, Bowen R, Mitchard J, et al. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells. Prostate. 2017;77:1312-1324 pubmed publisher
Wang C, Tseng T, Jhang Y, Tseng J, Hsieh C, Wu W, et al. Loss of cell invasiveness through PKC-mediated syndecan-1 downregulation in melanoma cells under anchorage independency. Exp Dermatol. 2014;23:843-9 pubmed publisher
Li K, Tipps A, Wang H. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting as an isolated nasopharyngeal mass: a case report and review of literature. Int J Clin Exp Pathol. 2010;4:190-6 pubmed
Beauvais D, Rapraeger A. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation. J Cell Sci. 2010;123:3796-807 pubmed publisher
Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani Matsuda M, Mekki Y, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol. 2010;185:717-28 pubmed publisher
Du S, Rashidi H, Le D, Kipps T, Broome H, Wang H. Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma. Int J Clin Exp Pathol. 2010;3:448-57 pubmed
Chang H, Jiang N, Jiang H, Saha M, Qi C, Xu W, et al. CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma. Haematologica. 2010;95:1542-7 pubmed publisher
Kim Y, Ko Y, Hong S, Kim K, Lee Y, Chae C, et al. Presence of Porphyromonas gingivalis and plasma cell dominance in gingival tissues with periodontitis. Oral Dis. 2010;16:375-81 pubmed publisher
Kylanpaa L, Hagstrom J, Lepistö A, Linjama T, Kärkkäinen P, Kiviluoto T, et al. Syndecan-1 and tenascin expression in cystic tumors of the pancreas. JOP. 2009;10:378-82 pubmed
Beauvais D, Ell B, McWhorter A, Rapraeger A. Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med. 2009;206:691-705 pubmed publisher
Mahshid Y, Lisy M, Wang X, Spanbroek R, Flygare J, Christensson B, et al. High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes. BMC Immunol. 2009;10:2 pubmed publisher
Yang Y, Macleod V, Dai Y, Khotskaya Sample Y, Shriver Z, Venkataraman G, et al. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood. 2007;110:2041-8 pubmed
Guedez L, Martinez A, Zhao S, Vivero A, Pittaluga S, Stetler Stevenson M, et al. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood. 2005;105:1660-8 pubmed
Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer. 1999;79:558-64 pubmed

product information

master code :

NBP2-25183

SKU :

NBP2-25183

product name :

LAMP-1/CD107a Antibody (H4A3) - Azide and BSA Free

unit size :

0.1 mg

description :

The LAMP-1/CD107a Antibody (H4A3) - Azide and BSA Free from Novus is a mouse monoclonal antibody to LAMP-1/CD107a. This antibody reacts with human,mouse,primate. The LAMP-1/CD107a Antibody (H4A3) - Azide and BSA Free has been validated for the following applications: Flow Cytometry,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,CyTOF-ready,Immunocytochemistry/ Immunofluorescence.

target :

LAMP-1/CD107a

category :

Primary Antibodies

buffer :

PBS

clonality :

Monoclonal

clone :

H4A3

concentration :

1.00 mg/ml

conjugate :

Unconjugated

host :

Mouse

immunogen :

Human PBMC

isotype :

IgG1

purity :

Protein A purified

species :

Human,Mouse,Primate

specificity :

The mouse monoclonal antibody H4A3 recognizes CD107a, an approximately 100-120 kDa glycoprotein expressed mainly on lysosomal, but also on the plasma membrane

theoretical molecular weight :

120 kDa

gene symbol :

LAMP1

applications :

Flow Cytometry,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,CyTOF-ready,Immunocytochemistry/ Immunofluorescence

extended description :

Clone H4A3 was used by HLDA to establish CD designation.

USD :

409 USD

product details :

Clone H4A3 was used by HLDA to establish CD designation.

alt names :

CD107 antigen-like family member A, CD107a, CD107a antigen, LAMP-1, LAMPA, LGP120, lysosomal-associated membrane protein 1, lysosome-associated membrane glycoprotein 1, Lysosome-associated membrane protein 1

storage :

Store at 4C. Do not freeze.

more info or order :

Novus Biologicals product webpage